Cancers, Vol. 12, Pages 1878: Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib
Conclusion: In 2D and 3D studies in vitro and in a syngeneic model in vivo, the combination of vandetanib plus radiotherapy was more efficacious than either treatment alone. This new combination therapy for HCC merits evaluation in clinical trials.
Source: Cancers - Category: Cancer & Oncology Authors: Sami Znati Rebecca Carter Marcos Vasquez Adam Westhorpe Hassan Shahbakhti Jessica Prince Petra Vlckova Chiara De Vellis Zainab Bascal Marilena Loizidou Ricky A. Sharma Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Hepatocellular Carcinoma | Liver Cancer | Study